Drug Manufacturers - Specialty & Generic | Healthcare
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respiratory, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. It exports its products to approximately 90 countries across Asia, North America, Europe, Africa, South America, and Australia. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.
Market Cap
4026075709440
Current Price
1678.0
52 Week Range
1553.05 - 1960.35
Previous Close
1692.3
Open
1686.1
Sector
Healthcare
Address
Sun House, CTS No. 201 B/1 Western Express Highway Goregaon (East), Mumbai, 400063, India
Phone
+91-22432-44324
Fax
+91-22432-44343
Website
https://sunpharma.com
Day Low
1672.8
Day High
1693.1
Dividend Yield
0.65
PE Ratio
36.86292
Earnings Per Share
45.52
Beta
0.361
EBITDA
149679407104
Book Value
300.992
EPS
51.91435
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Dilip Shantilal Shanghvi | MD & Executive Chairman of the Board | 69 | 1955 |
Mr. Aalok Dilip Shanghvi | COO, Head of Global Generics R&D, Business Devp., and Whole Time Director | 40 | 1984 |
Ms. Jayashree Satagopan | Executive VP & CFO | 56 | 1968 |
Mr. Dheeraj Prasad Sinha BE | EVP & Chief Information Officer | 53 | 1971 |
Dr. Abhishek Sharma | VP, Head of Investor Relations & Strategic Projects | - | - |
Mr. Anoop Deshpande | Company Secretary & Compliance Officer | - | - |
Mr. Kalyanasundaram Subramanian | Director of Corporate Development | 70 | 1954 |
Mr. Suresh Kumar Rai | Chief Human Resources Officer | - | - |
Mr. Kirti Wardhaman Ganorkar | Head of India Business | 57 | 1967 |
Dr. Azadar Hussain Asghar Mehdi Khan | Head of Corporate Relations & CSR - India Regulatory Affairs | 66 | 1958 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.